Benchling: Cloud-based informatics platform for bioscience R&D groups
Jun 27, 2024
Benchling: Cloud-based informatics platform for bioscience R&D groups
Benchling is a cloud-based platform powering biotechnology R&D. Its platform, the Benchling R&D Cloud, aims to replace traditional tools with a comprehensive digital environment tailored for life sciences workflows.
Benchling’s features include experiment design and tracking, a cloud-based electronic lab notebook, molecular biology software for tasks like DNA sequence analysis, inventory management, data visualization tools, and collaboration capabilities.
As of 2024, 200,000+ scientists at 1,200+ organizations globally use Benchling as their central system for R&D data management and analysis, including several global biopharma companies such as Regeneron, Gilead Sciences, and Sanofi.
The company surpassed USD 200 million in annualized revenue in 2024, with a 90% YoY increase in subscription revenue reported in 2022. Benchling initially filed confidential paperwork for an IPO in late 2021 but has not yet gone public as of early 2024.
Contact us
Gain access to all industry hubs, market maps, research tools, and more
Get a demo
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.